Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.68 |
| ▸ | IL23R | Q5VWK5 | 11/20 | 0.57 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30434320 | 0.93 | TFPI (0.66) | TFPIIL23RKEAP1 | |
| SCHEMBL29826865 | 0.93 | TFPI (0.66) | TFPIIL23RKEAP1 | |
| SCHEMBL31232421 | 0.91 | TFPI (0.56) | TFPIIL23RKEAP1 | |
| SCHEMBL10535233 | 0.90 | TFPI (0.62) | TFPIIL23RKEAP1 | |
| SCHEMBL10535214 | 0.90 | TFPI (0.62) | TFPIIL23RKEAP1 | |
| SCHEMBL30567797 | 0.90 | TFPI (0.62) | TFPIIL23RKEAP1 | |
| SCHEMBL30437374 | 0.90 | TFPI (0.63) | TFPI | |
| SCHEMBL30538334 | 0.89 | TFPI (0.67) | TFPIKEAP1 | |
| SCHEMBL31078236 | 0.89 | TFPI (0.53) | TFPIIL23RKEAP1 | |
| SCHEMBL30342387 | 0.88 | TFPI (0.57) | TFPIIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058858-A | GluA2 AMPAR endocytic blocking membrane-penetrating cyclic peptide and application thereof | 青岛大学 | 2025-05-30 | — | — | CN | disclosed |
| CN-115925813-A | Transmembrane cyclopeptide and preparation method and application thereof | 青岛大学 | 2023-04-07 | — | — | CN | disclosed |
| US-20220347266-A1 | METHOD AND MEDICINE FOR TREATING DEPRESSIVE DISORDERS | QINGDAO PRIMEDICINE PHARMACEUTICAL CO., LTD. (CN) | 2022-11-03 | — | — | US | disclosed |